Donation after circulatory death A.R. Manara, P.G. Murphy, G. O’Callaghan British Journal of Anaesthesia Volume 108, Pages i108-i121 (January 2012) DOI: 10.1093/bja/aer357 Copyright © 2012 The Author(s) Terms and Conditions
Fig 1 The clinical pathway for controlled DCD. Adapted from the Australian Guidelines on organ and tissue donation after death, for transplantation.27 British Journal of Anaesthesia 2012 108, i108-i121DOI: (10.1093/bja/aer357) Copyright © 2012 The Author(s) Terms and Conditions
Fig 2 Diagnostic categories of (a) the 3825 patients referred as potential controlled DCDs and (b) the 397 patients who went on to became actual controlled DCDs in the UK between October 2009 and December 2010 (data courtesy of NHSBT). British Journal of Anaesthesia 2012 108, i108-i121DOI: (10.1093/bja/aer357) Copyright © 2012 The Author(s) Terms and Conditions
Fig 3 The critical pathways for DBD and DCD as published by the World Health Organization.29 Reproduced with permission from John Wiley and Sons. British Journal of Anaesthesia 2012 108, i108-i121DOI: (10.1093/bja/aer357) Copyright © 2012 The Author(s) Terms and Conditions
Fig 4 (a) International variation in the number and type of deceased organ donors; (b) development of controlled DCD in Australia and the UK 2001–2010. British Journal of Anaesthesia 2012 108, i108-i121DOI: (10.1093/bja/aer357) Copyright © 2012 The Author(s) Terms and Conditions
Fig 5 Incidence of DBD and DCD in (a) the UK and (b) Australia, expressed in terms of donors per million population. Note that the DCD donors in the UK from 1993 to 1999 were exclusively uncontrolled donors (Maastricht categories I/II), while the increases beyond this time in both countries were controlled DCD (Maastricht categories III/IV). British Journal of Anaesthesia 2012 108, i108-i121DOI: (10.1093/bja/aer357) Copyright © 2012 The Author(s) Terms and Conditions